B. Górny

Low-dose of oral factor Xa inhibitors in patients with a recent acute coronary syndrome: a systematic review and meta-analysis of randomized trials.

G. Musumeci, R. Rossini, P. Gurbel, 2013, Atherosclerosis.

Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

H. Suryapranata, M. de Boer, F. Andreotti, 2014, The American journal of cardiology.

Underexpanded stent in left anterior descending coronary artery treated with intravascular lithotripsy

M. Ziolkowski, G. Grześk, Wojciech Balak, 2020, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

The Interactions of Nintedanib and Oral Anticoagulants—Molecular Mechanisms and Clinical Implications

A. Nowaczyk, G. Grześk, D. Rogowicz, 2020, International journal of molecular sciences.

Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome.

Sergio Berti, Malte Kelm, Marco Valgimigli, 2015, JACC. Cardiovascular interventions.

Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?

H. Suryapranata, E. Navarese, J. Kubica, 2013, American Journal of Cardiovascular Drugs.

First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients

H. Suryapranata, D. Kandzari, G. Musumeci, 2014, Open Heart.

Things to avoid in meta-analysis

M. Kowalewski, A. Szcześniak, B. Górny, 2013, European Journal of Preventive Cardiology.

First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients

H. Suryapranata, D. Kandzari, G. Musumeci, 2014, Open Heart.